当前位置：首页 > 文献互助 > 互助详情

119-OR: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Novel Ultra-Long-Acting GLP-1 Receptor Agonist (ZT002) in Healthy Subjects复制

用户cL9f8eBSIN4c 2个月前 55 10 已关闭

DOI:复制

文献链接:复制

其他信息:

上一篇：119-OR: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Novel Ultra-Long-Acting GLP-1 Receptor Agonist (ZT002) in Healthy Subjects

下一篇：Molecular Dynamics and Neural Network Analysis Reveal Sequential Gating and Allosteric Communication in FMRFamide-Activated Sodium Channels

互助时间线

2025-10-05 17:26:12 [关闭求助]

系统关闭了求助

2025-09-30 17:26:12 [发起求助]

最新发布的求助

Targeting human adenylate kinase 1 (hAK1) with phenylcyanomethylenequinone oximes: a novel scaffold of non-competitive inhibitors – synthesis, kinetic studies, SAR and QSAR analysis 12分钟前
Structure-guided design of a synthetic bile acid that inhibits Clostridioides difficile TcdB toxin 1小时前
A focused report on IFN-1 targeted therapies for lupus erythematosus 2小时前
Solid catalyst component for polymerization of olefins and catalyst 4小时前
Design and Analysis of Phase I Clinical Trials 4小时前
Blood-Brain Barrier Transport, Plasma Pharmacokinetics, and Neuropathology Following Chronic Treatment of the Rhesus Monkey with a Brain Penetrating Humanized Monoclonal Antibody Against the Human Transferrin Receptor 4小时前
Sudden Loss of Consciousness Following Psilocybin Ingestion 5小时前
Current updates in the epidemiology and comorbidities of atopic dermatitis 5小时前
Designer catalytic nanopores meet PET nanoparticles 6小时前
Interpretable machine learning for knowledge generation in heterogeneous catalysis 6小时前
Recent Progress in Electro- and Photocatalyst Discovery with Machine Learning 6小时前
Machine Learning for Electrocatalyst and Photocatalyst Design and Discovery 6小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com